CN Patent

CN110938077B — 合成Avapritinib的方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2021-04-27 · 5y expired

What this patent protects

本发明涉及一种合成avapritinib的方法。相对于现有合成路线的反应步骤多、收率低，并且要使用手性柱拆分手性化合物，本发明所述的方法大幅度减少了反应步数，提高了反应的总收率，有效降低了终产物成本，同时具有良好的实验操作性。

USPTO Abstract

本发明涉及一种合成avapritinib的方法。相对于现有合成路线的反应步骤多、收率低，并且要使用手性柱拆分手性化合物，本发明所述的方法大幅度减少了反应步数，提高了反应的总收率，有效降低了终产物成本，同时具有良好的实验操作性。

Drugs covered by this patent

Patent Metadata

Patent number
CN110938077B
Jurisdiction
CN
Classification
—
Expires
2021-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.